DC Consulting has recently completed the identification of preferred funder and then the subsequent negotiation of bank finance to allow one of its long standing clients to acquire enlarged premises to continues its growth plans from.
As part of this funding, additional working capital was also secured.
Jon Fleming, owner of Mochridhe, created a specialist care service that allows those receiving care to have control, choice and opportunity.
In 2006, after receiving a grant of £5,000 from the Princes Trust, Jon established Mochridhe, with the goal; The people we support will have control, choice and opportunity and will get the support which is of the highest quality, is flexible and dynamic as they need and choose.
With limited start up resources, the company has achieved growth and has secured contracts across both companies, providing in excess of 3,200 care hours per week, secured revenues of around £2million and employing over 100 staff.
DC Consulting oversaw the deal in which secured a £550,000 investment from Kelvin Capital Angel Investment syndicate.
This investment allows Mochridhe Ltd to continue to improve and expand on the quality care the company provides. Investment such as this would help the company’s growth plans set out by DC Consulting and with the future potential of creating further jobs within the company.
DC Consulting were delighted to assist Mochridhe Ltd in closing the deal, in order to help fulfil the companies continuous ambition to expand their care facilities to other that need it.
DC Consulting are delighted to have assisted Glasgow based iMetafilm, previously known as Windense, to secure equity funding from Kelvin Capital and the Scottish Investment Bank. The company uses digital SLR cameras to capture multiple pictures of the same film frame. That is then run through its Omniscan software while the images can also be tagged with relevant descriptions of what is in the shot. The business, which is already working with the American Library of Congress, says the resultant footage it transforms is then fully searchable.
Founders Michael and Linda Howell believe this could help convince companies to digitise old footage ranging from films and news reels to football matches and bands on tour. Mr Howell said: “At present, nobody fully knows what is there and people are even scared to open old film reels in case they get damaged. Our cost-effective technology can bring millions of forgotten or unseen moments into light, searchable by anyone on any device. Previously we were just thinking in terms of saving archive footage. However, having vast amounts of content without the ability to search it and scrutinise it is almost useless. Now we have a much more in-depth process which in turn makes it usable and more valuable. The potential is limitless, and it could be very personal. For example, in terms of genealogy imagine you could search for footage of war from the place and time where your ancestor served, or find a gig your parents went to decades ago.”
The funding is being used to build more scanning units and begin the labour intensive digitisation process for customers. Longer term iMetafilm hopes to have large scale scanning farms based in Scotland. Jim Hall, co-founder of Kelvin Capital, said: “This has the potential to be an industry game-changer, and is exactly the kind of Scottish-based technology business we love to support. It’s a hot area at the moment, and the size of the opportunity for whomever takes the lead is vast.”
Point Of Care Testing Ltd, (POCT Ltd) is a medical diagnostics distributor of point-of-care instruments and consumables for the medical and research markets in the UK and Ireland. POCT Ltd which also provides services to the National Independent Bowel Cancer Screening Programme, announced today the completion of a share purchase agreement to acquire 100% of the shares of Analox Instruments Ltd, (Analox) a United Kingdom based instrument and reagent manufacturing company. The transaction completed on 6th February 2015.
Ian Cowie, Managing Director and CEO of Point Of Care Testing Ltd, commented, “Throughout a long and successful period of distributing Point of Care products in the United Kingdom and Ireland, we now take over the additional manufacturing and distribution responsibilities of Analox Instruments by completing this acquisition. The range of products supplied by Analox Instruments is complementary to the POCT product portfolio and it now gives the company access to a global market resulting in a strengthened operational structure. We welcome the highly motivated and experienced Analox employees as new members to the POCT Ltd team. We also believe that in a complex market environment, this acquisition allows us to communicate the superior quality and performance of the POCT Ltd and Analox product ranges to the full benefit of our existing and future customers. Our goal is to build and strengthen our presence in the UK and additional geographic markets and to expand the growth potential of POCT Ltd into the future.” Ian Cowie and POCT was advised by DC Consulting throughout the transaction.
About POCT Ltd and Analox
POCT Ltd, founded in 2002, distributes a range of high quality Point of Care portable blood and urine analysis systems for use in any human patient-care setting in order to provide clinicians with rapid blood constituent measurements, throughout the UK and Ireland. These products include the Abaxis Piccolo xpress™, the Abbott i-STAT®, the Hemoccult® Brand from Beckman Coulter, and a range of ACON Laboratories analysers and rapid tests. POCT Ltd also provides routine laboratory testing for the National Independent Bowel Cancer Screening Programme (NIBCSP).
Analox Instruments, founded in 1973 has over 40 years experience and produces high quality analyser systems for the measurement of a wide variety of analytes including rapid enzymatic analysis for glucose, lactate, cholesterol, urea sucrose, lactose, glycerol, ethanol and methanol with applications in Clinical Research, Biotechnology, Sports Science, Food, Pharmaceuticals, Cosmetics and Beverages. Products are used in over 65 countries world-wide including North America, Japan, Malaysia, Australasia and most European countries. Two thirds of the Company’s output is exported, mostly through distributors.
